AstraZeneca: all 4,196 studies
Page 38 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)CompletedNCT00608712Phase 4
- Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent AsthmaCompletedNCT00608218
- Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/HydrochlorothiazideCompletedNCT00608153
- Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVHCompletedNCT00607633
- A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)CompletedNCT00600496Phase 1
- Quality of Life in Schizophrenic PatientsCompletedNCT00597168
- A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal CancerCompletedNCT00590278Phase 2
- Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEXCompletedNCT00590213Phase 4
- A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)TerminatedNCT00587015Phase 1
- Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCompletedNCT00585143Phase 1
- A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced MelanomaTerminatedNCT00585000Phase 1
- Exenatide Pregnancy Registry - Type 2 Diabetes in PregnancyTerminatedNCT00579150
- A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557CompletedNCT00578682Phase 1
- An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance MedicationCompletedNCT00577265
- Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)CompletedNCT00574782
- Efficacy Observational Study of Candesartan Cilexetil on Hypertensive PatientsCompletedNCT00573742
- Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe AsthmaCompletedNCT00573222
- Open Label, Dose Escalation Phase I Study of AZD2281CompletedNCT00572364Phase 1
- A Post Marking Study to Evaluate the Safety of FluMist in ChildrenCompletedNCT00569894
- LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)CompletedNCT00567619
- German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-SymptomsCompletedNCT00567021
- SYMBICORT® in the Treatment of COPDCompletedNCT00564499
- Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast CancerCompletedNCT00562458
- Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsCompletedNCT00562250Phase 1
- Electronic Study for Anastrozole Pharmacovigilance EvaluationCompletedNCT00558168
- Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of DyslipidemiaCompletedNCT00557778
- NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single InhalerCompletedNCT00557297
- A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic CancerCompletedNCT00556023Phase 1
- Patient's Anastrozole Compliance to Therapy ProgrammeTerminatedNCT00555867
- Renal Impairment in Type 2 Diabetic SubjectsCompletedNCT00554450Phase 1
- Drug Interaction With MetforminCompletedNCT00546741Phase 1
- Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)CompletedNCT00546520Phase 3
- Impact of GERD on Daily Life (NIS)CompletedNCT00545883
- A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast CancerCompletedNCT00544986Phase 4
- Antibiotic Therapy for Hospital-Acquired Infections in ICU PatientsCompletedNCT00543894
- Effectiveness of Anti-Psychotic in GPs SettingCompletedNCT00543088
- Pan-European Survey on the Under Treatment of HypercholesterolemiaCompletedNCT00542867
- Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant TherapyTerminatedNCT00542594
- A Phase II Study of MEDI-507, Administered by Injection to Adults With PsoriasisCompletedNCT00540618Phase 2
- Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP TrialCompletedNCT00540059
- Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer PatientsTerminatedNCT00539331Phase 1
- Phase I Multiple-Ascending Dose (Japan)CompletedNCT00538174Phase 1
- A Phase I Study to Evaluate Safety, Tolerability in Adults With LymphomaWithdrawnNCT00538096Phase 1
- Percentage of Secondary Prevention Patients Treated to Their LDL-C TargetsCompletedNCT00536965
- Percentage of Secondary Prevention Patients Treated to Their LDL-C TargetsCompletedNCT00536796
- What is the Predictive Value of the Reflux Impact ScaleTerminatedNCT00536328
- Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine EffectCompletedNCT00534222
- A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)CompletedNCT00533260
- A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or PolymyositisCompletedNCT00533091Phase 1
- A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®CompletedNCT00532922
- Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)CompletedNCT00530699Phase 1
- Proof of Concept Study of Cognitive Improvement in Patients With SchizophreniaCompletedNCT00528905Phase 2
- Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTIONCompletedNCT00526721
- Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )CompletedNCT00526708
- Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)CompletedNCT00526552
- COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand PlusCompletedNCT00526279
- Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single InhalerCompletedNCT00524641
- Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERDCompletedNCT00524355
- Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI DamageCompletedNCT00524329
- The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux PatientsCompletedNCT00524251
- InPractice Survey on the Treatment of HypercholesterolemiaCompletedNCT00523796
- Seroquel Long-Term NIS for Schizophrenia PatientsCompletedNCT00523783
- Symbicort SMART (Symbicort Maintenance And Reliever Therapy)CompletedNCT00523679
- Quetiapine Efficacy in Bipolar Depression StudyCompletedNCT00523601
- Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNtsCompletedNCT00523484
- APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)CompletedNCT00523315
- A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 DiabetesCompletedNCT00517283Phase 1
- A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With DacarbazineCompletedNCT00516802Phase 1
- Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelCompletedNCT00516724Phase 1
- Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With TopotecanCompletedNCT00516438Phase 1
- A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)CompletedNCT00516373Phase 1
- Diabetic Under 70 (Diabetics Below 70)CompletedNCT00516204
- Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic CancerCompletedNCT00515866Phase 1
- Be SMART NIS, Moderate to Servere Asthma Patient ObservationCompletedNCT00514787
- Phase II Efficacy Study of AZD6244 in Colorectal CancerCompletedNCT00514761Phase 2
- A Sequential Dose-Escalation Study in Subjects With Mild AsthmaCompletedNCT00512486Phase 1
- A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeCompletedNCT00505388
- Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedNCT00504062Phase 3
- A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in JapanCompletedNCT00503477Phase 1
- Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic TumorsCompletedNCT00503412Phase 1
- Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain TumourCompletedNCT00503204Phase 1
- A Pharmaceopidemiological Study in Patients Who Use Symbicort SMARTCompletedNCT00503061
- A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid TumorsCompletedNCT00502567Phase 1
- Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AMLCompletedNCT00502385Phase 1
- Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate CancerCompletedNCT00502164Phase 1
- Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced CancerCompletedNCT00502060Phase 1
- Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver MetastasesCompletedNCT00501605Phase 1
- Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's DiseaseCompletedNCT00501111Phase 2
- Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00497991Phase 1
- AZD1152 in Patients With Advanced Solid Malignancies-Study 1TerminatedNCT00497731Phase 1
- AZD1152 in Patients With Advanced Solid Malignancies-Study 3TerminatedNCT00497679Phase 1
- Phase I Study in Patients With Solid TumoursCompletedNCT00496028Phase 1
- AZD6765 for Treatment Resistant DepressionCompletedNCT00491686Phase 2
- Interaction Between ABT-335, Rosuvastatin and WarfarinCompletedNCT00487136Phase 1
- FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTerminatedNCT00486798Phase 3
- Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic AsthmaCompletedNCT00485576Phase 2
- A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus ErythematosusCompletedNCT00482989Phase 1
- A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy AdultsCompletedNCT00480155Phase 2
- Iressa as Second Line Therapy in Advanced NSCLC-AsiaCompletedNCT00478049Phase 3
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusCompletedNCT00477581Phase 4